-Ngi ang dng thuc iu tr nn tham kho kin bc s trc khi dng
Back to Journals Integrated Pharmacy Research and Practice Volume 14 Molecular Pharmacology of Glucagon-Like Peptide 1-Based Therapies in the Management of Type Two Diabetes Mellitus and Obesity Authors Alzahrani AM, Alshobragi GA, Alshehri AM, Alzahrani MS, Alshehri HA, Alzhrani RM, Basudan S, Alkatheeri AA, Almutairi SA, Alzahrani YA Received 12 November 2024 Accepted for publication 13 March 2025 Published 6 April 2025 Volume 2025:14 Pages 5972 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Walid Al-Qerem Abdullah M Alzahrani, 1 3 Ghada A Alshobragi, 1 Abdullah M Alshehri, 1 Majed S Alzahrani, 1 Hasan A Alshehri, 1 Rami M Alzhrani, 4 Samah Basudan, 5 Ayed A Alkatheeri, 6 Salman A Almutairi, 7 Yahya A Alzahrani 2, 6 1 Pharmaceutical Care Department, Ministry of National GuardHealth Affairs, Jeddah, 22384, Saudi Arabia
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a portion of a naturally occurring protein found in gastric juice
A low-quality BAC water could have impurities, an incorrect concentration of benzyl alcohol, or may not have undergone proper sterility testing
Estudios clnicos y dcadas de uso confirman que el glutatin es extremadamente seguro para la mayora de los adultos, con efectos secundarios poco frecuentes
